Form D · Other Health Care

Regenicin, Inc.

New York, NY · CIK 0001412659

Offering snapshot reported Oct 18, 2010 · SEC filing

Reported sold
Yet to sell
Offering amount: $3.5M
Investors reported
0
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 18, 2010InitialYet to sellNo comparison0SEC filing
Aug 2, 2010InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$420K (estimated)
Finders' fees
$0
Form D file number
021-149220
Aside from a 10% cash fee, the broker may receive warrants to purchase common stock up to 5% of the aggregate offering amount.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Legend Securities Inc.44952Legend Securities Inc. · CRD 44952

Source: Form D, filed Oct 18, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Connell Executive
Craig Eagle Director
Chris Hadsall Executive
Randall Mc Coy Director, Executive
J. Roy Nelson Executive
Joseph Rubinfeld Director
David Schmidt Executive
John J. Weber Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
470 Park Avenue South 16 Th Floor
New York, NY, 10010